Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
F:PCJ

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
F:PCJ
Watchlist
Price: 5.952 EUR -2.71%
Market Cap: €243.8m

Wall St Price Targets

PCJ Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast PCJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCJ is 16.272 EUR with a low forecast of 11.442 EUR and a high forecast of 23.79 EUR.

Lowest Forecast
Price Target
11.442 EUR
92% Upside
Average Forecast
Price Target
16.272 EUR
173% Upside
Highest Forecast
Price Target
23.79 EUR
300% Upside
Abeona Therapeutics Inc Competitors:
Price Targets
LGI
Lgi Ltd
72% Upside
TELA
TELA Bio Inc
181% Upside
PTCT
PTC Therapeutics Inc
17% Upside

Revenue
Forecast

9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

Gross Profit
Forecast

7% / Year
Past Growth
280% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
280% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.

Net Income
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCJ's stock price target?
Price Target
16.272 EUR

According to Wall Street analysts, the average 1-year price target for PCJ is 16.272 EUR with a low forecast of 11.442 EUR and a high forecast of 23.79 EUR.

What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.

What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.

What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
18%

The compound annual growth rate for Net Income over the next 8 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett